Michael J. Farrell - 19 Aug 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
19 Aug 2021
Transactions value $
$0
Form type
4
Filing time
20 Aug 2021, 11:57:23 UTC
Previous filing
02 Jul 2021
Next filing
04 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +18.4K +4.53% $0.00 425K 19 Aug 2021 Direct F1, F2
holding RMD ResMed Common Stock 8.97K 19 Aug 2021 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.
F2 Includes 33.4591 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan.